BTRX-246040 Uses, Dosage, Side Effects and more
BTRX-246040 is under investigation in clinical trial NCT03193398 (BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder).
| Trade Name | BTRX-246040 |
| Generic | BTRX-246040 |
| Type | |
| Formula | C22H23ClF2N4O2S |
| Weight | Average: 480.96 Monoisotopic: 480.1198312 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
